Horizon Technology Finance, an affiliate of Monroe Capital, provided a $15 million senior credit facility to Bioness Medical, with an initial $10 million funded at closing, and up to $5 million available to support Bioness’s continued growth.
“Providing flexible growth capital to innovative companies with proven business models and strong market positions is a core focus of Horizon’s venture lending platform,” Paul Seitz, chief investment officer of Horizon, said. “Our team has extensive experience partnering with healthcare and life sciences companies and delivering tailored financing solutions that help management teams execute on their growth objectives. Bioness is representative of the high-quality businesses we seek to support, and we are pleased to add another leading healthcare technology company to Horizon’s portfolio. We look forward to continuing to deploy capital in support of innovative companies across our target markets.”
Todd Cushman, co-founder and CEO of Bioness, added, “Horizon’s deep understanding of the life sciences sector and ability to structure a financing solution tailored to our needs made them an attractive partner. This facility provides additional capital and flexibility as we continue investing in innovation, expanding our product portfolio and serving patients and healthcare providers around the world.”
